1 / 1
Vadadustat(Vafseo)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Reference price:
Manufacturer:
Akebia Therapeutics
Formulation:
TABLET
Validity period:
36 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of
a
pharmacist. For read by medical and pharmaceutical professionals only.
Vafseo(Vadadustat) Instructions:Uses,Dosage, Side Effects
VAFSEO, with the generic name vadadustat, is an orally administered hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor. It received initial U.S. approval in 2024. The medication is formulated as film-coated, immediate-release tablets designed for once-daily oral administration. Its primary pharmacological action involves stabilizing hypoxia-inducible factors to stimulate endogenous erythropoietin production, thereby supporting red blood cell formation in eligible patient populations.
